CTT Pharmaceutical names new CFO and strategic advisor
28 November 2019 -

CTT Pharmaceutical Holdings Inc, (OTC: CTTH), a life sciences company with a portfolio of IP in novel drug delivery systems, announced yesterday that it has named Bob Allen as its new CFO and Marc Lakmaaker as strategic advisor.

Allen has acted as both CFO and CEO to large public corporations, including Ainsworth Lumber and the TimberWest Forest Corporation. He is an investor, entrepreneur and C-Suite executive with more than 20 years of experience in building, leading, and advising both public and private companies, including executing M&A and capital market transactions.

Lakmaaker is an executive with more than 20 years of capital markets, management and communications experience. He has knowledge of the cannabis industry, with a strong network of analysts, investors, influencers and industry participants. Lakmaaker is the founder of Clearview Capital Consult, a strategic and communications advisory focused on the cannabis, technology and industrial technology sectors. Prior to this, he was head of investor relations and director of Corporate Development at Aurora Cannabis. He will be working with management on the development and execution of corporate and capital markets strategies.